Atıf Formatları
Loss of cyclin-dependent kinase inhibitor p27 is a novel early marker in human gastric cancer: An immunohistochemical study
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

A. S. ERDAMAR ÇETİN Et Al. , "Loss of cyclin-dependent kinase inhibitor p27 is a novel early marker in human gastric cancer: An immunohistochemical study," LABORATORY INVESTIGATION , vol.79, no.1, 1999

ERDAMAR ÇETİN, A. S. Et Al. 1999. Loss of cyclin-dependent kinase inhibitor p27 is a novel early marker in human gastric cancer: An immunohistochemical study. LABORATORY INVESTIGATION , vol.79, no.1 .

ERDAMAR ÇETİN, A. S., Gocener, S., Dogusoy, G., & Goksel, S., (1999). Loss of cyclin-dependent kinase inhibitor p27 is a novel early marker in human gastric cancer: An immunohistochemical study. LABORATORY INVESTIGATION , vol.79, no.1.

ERDAMAR ÇETİN, Ayşe Et Al. "Loss of cyclin-dependent kinase inhibitor p27 is a novel early marker in human gastric cancer: An immunohistochemical study," LABORATORY INVESTIGATION , vol.79, no.1, 1999

ERDAMAR ÇETİN, Ayşe S. Et Al. "Loss of cyclin-dependent kinase inhibitor p27 is a novel early marker in human gastric cancer: An immunohistochemical study." LABORATORY INVESTIGATION , vol.79, no.1, 1999

ERDAMAR ÇETİN, A. S. Et Al. (1999) . "Loss of cyclin-dependent kinase inhibitor p27 is a novel early marker in human gastric cancer: An immunohistochemical study." LABORATORY INVESTIGATION , vol.79, no.1.

@article{article, author={Ayşe Sibel ERDAMAR ÇETİN Et Al. }, title={Loss of cyclin-dependent kinase inhibitor p27 is a novel early marker in human gastric cancer: An immunohistochemical study}, journal={LABORATORY INVESTIGATION}, year=1999}